Pay in 4 interest-free payments of $29.38 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
5-dioxo-1-((6-(5-((3aS
and orally available pan-Akt inhibitor
1007/s40265-017-0816-z
InChi: InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H
2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-N
GV-58 60427 5-dioxo-1-((6-(5-((3aSGV 58 is a potent, selective N and P Q type Ca2+ channels agonist with EC50 of 7. 21 8. 81 uM for N type P Q type Ca2+ channel; 20 fold less potent CDK inhibitor activity. IC50 value: 7. 21 8. 81 uM (N type P Q type Ca2+ channel) Target: Ca2+ channel agonistIn comparison with the parent molecule, (R) roscovitine, GV 58 has a 20 fold less potent cyclin dependent kinase antagonist effect, a 3 to 4 fold more potent Ca2+ channel agonist effect, and 4 fold
US$ 19.99
US$ 29.99
US$ 26.00
US$ 38.99
US$ 10.00
US$ 29.99
US$ 28.99
US$ 40.99
US$ 28.99
US$ 22.00